The researcher whose report prompted a spike in health stocks last month appears to have relied on lobbyists rather than U.S. government insiders who had direct knowledge of a pending healthcare decision, according to emails reviewed by Reuters. The messages could help bolster Height Securities LLC's claim that its analyst was essentially doing what reporters, lobbyists and others in Washington do every day: trying to figure out what the government is going to do next. The small research shop is among the brokerages, law firms and other "political intelligence" operations that have drawn scrutiny over concerns that they may have facilitated insider trading by passing along tips that moved markets. Height Securities has drawn inquiries from the Securities and Exchange Commission and Iowa Republican Senator Charles Grassley since it correctly predicted on April 1 that President Barack Obama's administration would keep certain medical payment rates in place, prompting
↧